CN106620233A - Medicament for treating diabetes mellitus in dogs and cats in adjuvant way and preparation method thereof - Google Patents
Medicament for treating diabetes mellitus in dogs and cats in adjuvant way and preparation method thereof Download PDFInfo
- Publication number
- CN106620233A CN106620233A CN201710132278.8A CN201710132278A CN106620233A CN 106620233 A CN106620233 A CN 106620233A CN 201710132278 A CN201710132278 A CN 201710132278A CN 106620233 A CN106620233 A CN 106620233A
- Authority
- CN
- China
- Prior art keywords
- root
- grams
- radix
- percent
- medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 44
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 40
- 241000282326 Felis catus Species 0.000 title claims abstract description 26
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 241000282472 Canis lupus familiaris Species 0.000 title abstract 3
- 239000002671 adjuvant Substances 0.000 title abstract 2
- 238000000034 method Methods 0.000 claims abstract description 16
- 240000002853 Nelumbo nucifera Species 0.000 claims abstract description 13
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims abstract description 13
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims abstract description 13
- 238000005303 weighing Methods 0.000 claims abstract description 4
- 238000011282 treatment Methods 0.000 claims description 36
- 244000247747 Coptis groenlandica Species 0.000 claims description 13
- 235000002991 Coptis groenlandica Nutrition 0.000 claims description 13
- 241001412627 Adenophora liliifolia Species 0.000 claims description 12
- 244000241872 Lycium chinense Species 0.000 claims description 12
- 235000015468 Lycium chinense Nutrition 0.000 claims description 12
- 240000002948 Ophiopogon intermedius Species 0.000 claims description 12
- 241000405414 Rehmannia Species 0.000 claims description 9
- 238000003304 gavage Methods 0.000 claims description 3
- 241000050051 Chelone glabra Species 0.000 claims 4
- 239000008280 blood Substances 0.000 abstract description 11
- 210000004369 blood Anatomy 0.000 abstract description 11
- 230000008569 process Effects 0.000 abstract description 5
- 231100000957 no side effect Toxicity 0.000 abstract description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 2
- 238000001035 drying Methods 0.000 abstract description 2
- 239000008103 glucose Substances 0.000 abstract 1
- 238000005406 washing Methods 0.000 abstract 1
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 20
- 230000000694 effects Effects 0.000 description 11
- 102000004877 Insulin Human genes 0.000 description 10
- 108090001061 Insulin Proteins 0.000 description 10
- 229940125396 insulin Drugs 0.000 description 10
- 241000207929 Scutellaria Species 0.000 description 8
- 210000003734 kidney Anatomy 0.000 description 7
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 230000001684 chronic effect Effects 0.000 description 5
- 230000007812 deficiency Effects 0.000 description 5
- 230000007774 longterm Effects 0.000 description 5
- 235000013305 food Nutrition 0.000 description 4
- 201000001421 hyperglycemia Diseases 0.000 description 4
- 230000001502 supplementing effect Effects 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 235000019640 taste Nutrition 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000002641 glycemic effect Effects 0.000 description 2
- 230000003914 insulin secretion Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 208000030159 metabolic disease Diseases 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 102000051325 Glucagon Human genes 0.000 description 1
- 108060003199 Glucagon Proteins 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 241000218989 Trichosanthes Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 1
- 229960004666 glucagon Drugs 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/342—Adenophora
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/808—Scrophularia (figwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8964—Anemarrhena
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicament for treating diabetes mellitus in dogs and cats in an adjuvant way and a preparation method thereof. The medicament is prepared from the following components in percentage by weight: 5.68 percent of rhizoma coptidis, 17.05 percent of pollen, 17.05 percent of radix rehmanniae, 5.68 percent of radix ophiopogonis, 5.68 percent of anemarrhenae, 11.36 percent of radix scrophulariae, 5.68 percent of radix scutellariae, 9.09 percent of radix adenophorae, 5.68 percent of cortex lycii radices and 17.05 percent of lotus root juice. The preparation method comprises the following steps: washing the rhizoma coptidis, radix rehmanniae, radix ophiopogonis, anemarrhenae, radix scrophulariae, radix scutellariae, radix adenophorae and cortex lycii radices, and baking, drying or airing the pollen for later use; weighing 5g of rhizoma coptidis, 15g of pollen, 15g of radix rehmanniae, 5g of radix ophiopogonis, 5g of anemarrhenae, 10g of radix scrophulariae, 5g of radix scutellariae, 8g of radix adenophorae and 5g of cortex lycii radices for every dose of medicament, mixing and decocting to obtain a decoction, and adding 15g of lotus root juice to be taken together. Each dose of the medicament has no side effect; the formula and the process are simple, the cost is low, and the blood glucose of the dogs and cats can be lowered effectively after the medicament is taken for a while.
Description
Technical field
The invention belongs to pet medicine technology field, more particularly to a kind of auxiliary treatment dog cat diabetes medicament and its preparation
Method.
Background technology
Diabetes are a kind of lifelong diseases, and its treatment in the middle of the pets such as dog cat is related to living-pattern preservation, various
The reasonable application of medicine.Diabetes can be completely effectively effected a radical cure currently without any medicine.In traditional Chinese medicine, diabetes spp in
" quenching one's thirst ", " oedema " disease category, is the card of " asthenia in origin and asthenia in superficiality, simulataneous insufficiency and excessive ", is referred to because of lung, stomach, the dirty scorching deficiency of Yin of kidney three, water paddy
Thirsty many drink, rapid digestion of food and polyorexia, urinary micturition or turbid urines caused by defeated cloth is not normal and pleasantly sweet, body is gradually become thin as main spy
The disease levied.When being developed simultaneously with eliminating evil with righting, clinic should be based on supplementing qi and nourishing yin, enriching yin and nourishing kidney treatment for treatment.Western modern medicine is being controlled
Treat and secondary failure, large side effects are gradually shown in diabetes and not enough shortcoming is prevented and treated to chronic complicating diseases；Chinese medicine is with it
Toxic and side effect is little, action temperature and persistently, have the advantages that complex treatment is acted on and can delay complication, searching hypoglycemic of can yet be regarded as
One important channel of new drug.By reading substantial amounts of document, it is understood that Coptis herbaceos perennial, bitter
It is cold, it is heat-clearing and damp-drying drug class Chinese medicine；Root of Chinese trichosanthes, radix rehmanniae recen can promote insulin level to raise, and Plasma Glucagon Level is reduced, so as to
Blood sugar is effectively reduced, in conjunction with the curative effects such as the supplementing qi and nourishing yin in Chinese traditional treatment theory, enriching yin and nourishing kidney and modern Chinese medicine blood sugar-reduction formula
Blood-sugar lowering tcm drug is commonly used in agent, has formulated exclusive prescription " ten taste blood sugar reducing liquids "：The coptis, pollen, the dried rhizome of rehmannia, the tuber of dwarf lilyturf, the wind-weed, radix scrophulariae, scutellaria,
The root of straight ladybell, the root bark of Chinese wolf-berry, lotus root juice, in this, as our research medicine.
In sum, western modern medicine treatment diabetes in gradually show secondary failure, large side effects and to it is chronic simultaneously
Send out the not enough shortcoming of disease preventing and treating.
The content of the invention
It is an object of the invention to provide a kind of auxiliary treatment dog cat diabetes medicament and preparation method thereof, it is intended to solve west
Medicine gradually shows secondary failure, large side effects in treatment diabetes and prevents and treats not enough problem to chronic complicating diseases.
The present invention is achieved in that a kind of auxiliary treatment dog cat diabetes medicament, the treatment dog cat diabetes medicament
According to percentage by weight by the coptis 5.68%, pollen 17.05%, the dried rhizome of rehmannia 17.05%, the tuber of dwarf lilyturf 5.68%, the wind-weed 5.68%, radix scrophulariae
11.36%th, the root of large-flowered skullcap 5.68%, the root of straight ladybell 9.09%, the root bark of Chinese wolf-berry 5.68% and lotus root juice 17.05% are constituted.
Another object of the present invention is to a kind of preparation method of the auxiliary treatment dog cat diabetes medicament is provided, it is described
The preparation method of auxiliary treatment dog cat diabetes medicament is comprised the following steps：
Step one, first the coptis, radix rehmanniae recen, the tuber of dwarf lilyturf, the wind-weed, radix scrophulariae, the root of large-flowered skullcap, the root of straight ladybell, the root bark of Chinese wolf-berry, it is clean after, Yi Jihua
Powder dries, dries or dries standby；
Step 2, the component per auxiliary carry out weighing by weight 5 grams of the coptis, 15 grams of pollen, 15 grams of the dried rhizome of rehmannia, 5 grams of the tuber of dwarf lilyturf,
5 grams of the wind-weed, 10 grams of radix scrophulariae, 5 grams of the root of large-flowered skullcap, 8 grams of the root of straight ladybell, 5 grams of the root bark of Chinese wolf-berry, are brewed into decoction after mixing plus 15 grams of lotus root juice takes.
Further, the using method of the auxiliary treatment dog cat diabetes medicament is：By the coptis, pollen, the dried rhizome of rehmannia, the tuber of dwarf lilyturf,
Decoction is brewed into after the wind-weed, radix scrophulariae, the root of large-flowered skullcap, the root of straight ladybell, root bark of Chinese wolf-berry mixing, plus lotus root juice takes, one time a day gavages.
Auxiliary treatment dog cat diabetes medicament that the present invention is provided and preparation method thereof, shows from traditional doctor trained in Western medicine theory；West
Doctor's viewpoint：Diabetes are the metabolic diseases being characterized with hyperglycaemia, and chronic hyperglycemia often results in various internal organs, especially eye,
Kidney, neural and cardiovascular long-term damage, be one group by defect of insulin secretion and (or) infringement, insufficiency and exhaustion.But
Consider from traditional Chinese medical science viewpoint：Diabetes can belong in diabetes category, and diabetes clinical manifestation is many drinks, many foods, diuresis, body disappear
It is thin, or urinate pleasantly sweet, the traditional Chinese medical science thinks that its interpretation of the cause, onset and process of an illness mainly examines tax deficiency, YIN fluid deficiency, scorching inclined victory.TCM Treatment of Diabetes
More with supplementing qi and nourishing yin and enriching yin and nourishing kidney as the main rules for the treatment of.The present invention has no side effect per auxiliary, can long-term taking, inventive formulation,
Process is simple, it is with low cost, can effectively reduce dog cat blood sugar after taking a period of time.In order to ensure curative effect, initial stage is treated
Using the method for the combination of Chinese tradiational and Western medicine, to make up the shortcoming that alone " ten taste blood sugar reducing liquids " can not take effect in a short time.
Description of the drawings
Fig. 1 is the preparation method flow chart of auxiliary treatment dog cat diabetes medicament provided in an embodiment of the present invention.
Specific embodiment
In order that the objects, technical solutions and advantages of the present invention become more apparent, with reference to embodiments, to the present invention
It is further elaborated.It should be appreciated that specific embodiment described herein is not used to only to explain the present invention
Limit the present invention.
The application principle of the present invention is explained in detail below in conjunction with the accompanying drawings.
Auxiliary treatment dog cat diabetes medicament provided in an embodiment of the present invention is according to percentage by weight by the coptis 5.68%, flower
Powder 17.05%, the dried rhizome of rehmannia 17.05%, the tuber of dwarf lilyturf 5.68%, the wind-weed 5.68%, radix scrophulariae 11.36%, the root of large-flowered skullcap 5.68%, the root of straight ladybell
9.09%th, the root bark of Chinese wolf-berry 5.68% and lotus root juice 17.05% are constituted.
As shown in figure 1, the preparation method of auxiliary treatment dog cat diabetes medicament provided in an embodiment of the present invention is including following
Step：
S101：First the coptis, radix rehmanniae recen, the tuber of dwarf lilyturf, the wind-weed, radix scrophulariae, the root of large-flowered skullcap, the root of straight ladybell, the root bark of Chinese wolf-berry, it is clean after, and pollen
Dry, dry or dry and be standby；
S102：Component per auxiliary carries out weighing by weight 5 grams of the coptis, 15 grams of pollen, 15 grams of the dried rhizome of rehmannia, 5 grams of the tuber of dwarf lilyturf, knows
Female 5 grams, 10 grams of radix scrophulariae, 5 grams of the root of large-flowered skullcap, 8 grams of the root of straight ladybell, 5 grams of the root bark of Chinese wolf-berry, are brewed into decoction plus 15 grams of lotus root juice take after mixing.
A kind of using method of auxiliary treatment dog cat diabetes medicament of the present invention, the using method is：Above medicinal material (is removed
Lotus root juice) decoction is brewed into plus 15 grams of lotus root juice takes after mixing, one time a day gavages, can long-term taking.
Analyze with reference to pharmacological and the application principle of the present invention is explained in detail.
The present invention treats method of the initial stage using the combination of Chinese tradiational and Western medicine in order to ensure curative effect, to make up alone " ten tastes drop
The shortcoming that liquid glucose " can not take effect in a short time；For the new approaches that medical worker from now on provides treatment；It is theoretical from traditional doctor trained in Western medicine
Show；Doctor trained in Western medicine viewpoint：Diabetes are the metabolic diseases being characterized with hyperglycaemia, and chronic hyperglycemia often results in various internal organs, especially
It is eye, kidney, neural and cardiovascular long-term damage, be one group by defect of insulin secretion and (or) infringement, insufficiency and
Exhaustion.But consider from traditional Chinese medical science viewpoint：Diabetes can belong in diabetes category, and diabetes clinical manifestation is many drinks, many foods, many
Urine, body are become thin, or urinate pleasantly sweet, and the traditional Chinese medical science thinks that its interpretation of the cause, onset and process of an illness mainly examines tax deficiency, YIN fluid deficiency, scorching inclined victory.Traditional Chinese medicine
Treatment diabetes with supplementing qi and nourishing yin and control kidney method as the main rules for the treatment of more.The present invention has no side effect per auxiliary, can long-term taking.This
Bright formula, process is simple, it is with low cost, the blood sugar for suffering from diabetes dog cat can be substantially reduced after taking a period of time.
The application effect of the present invention is explained in detail with reference to specific embodiment.
Embodiment：
The old bitch at one about 11 years old age, with drowsiness, pain over renal region, drinks many food diuresis but build more in September, 2014
The symptom such as lose weight of becoming thin is gone to a doctor in Rongchang County of Southwestern University school district pets hospital, and menses sugar instrument monitoring and routine blood test monitor it
Afterwards, it is diagnosed as：Diabetes.At that time hospital took insulin injection to control blood sugar, insulin injection after two hours blood sugar it is obvious
Reduce, doctor's suggestion is suffered from dog and need to daily inject quantitative insulin to control blood sugar, and be possible to insulin occur later to resist
Property need to improve insulin dosage.Afterwards really as described in doctor, insulin dosage is gradually increased and just make glycemic control in normal model
Enclose interior and pain over renal region symptom not improving.Adopt the technical scheme, insulin dosage simultaneously in December, 2014 later
Slowly successively decrease, insulin is stopped using in November, 2015, continue to adopt the patent treatment, later Jing the method treatment phase
Between glycemic control in normal range (NR), pain over renal region slightly mitigates, and drinks diuresis symptom mitigation more, and fur is gradually bright, and build is returned
Reform often, this treatment method also stops after in May, 2016.So far insulin stops injection more than 1 year, the technology treatment method
Stop eight months as long as, blood sugar is constantly in normal level.During being treated using the treatment technology, hospital also sees and treat patients successively
The diabetes of several old dog cats, are treated using above method, and the case of the Jing patent of invention auxiliary treatments reaches
Preferably adjuvant treatment effect is so as to reaching good therapeutic effect.
Presently preferred embodiments of the present invention is the foregoing is only, not to limit the present invention, all essences in the present invention
Any modification, equivalent and improvement made within god and principle etc., should be included within the scope of the present invention.
Claims (3)
1. a kind of auxiliary treatment dog cat diabetes medicament, it is characterised in that the auxiliary treatment dog cat diabetes medicament is according to weight
Amount percentage is by the coptis 5.68%, pollen 17.05%, the dried rhizome of rehmannia 17.05%, the tuber of dwarf lilyturf 5.68%, the wind-weed 5.68%, radix scrophulariae
11.36%th, the root of large-flowered skullcap 5.68%, the root of straight ladybell 9.09%, the root bark of Chinese wolf-berry 5.68% and lotus root juice 17.05% are constituted.
2. a kind of preparation method of auxiliary treatment dog cat diabetes medicament as claimed in claim 1, it is characterised in that the auxiliary
The preparation method for the treatment of dog cat diabetes medicament is comprised the following steps：
Step one, first the coptis, radix rehmanniae recen, the tuber of dwarf lilyturf, the wind-weed, radix scrophulariae, the root of large-flowered skullcap, the root of straight ladybell, the root bark of Chinese wolf-berry, clean after, and pollen roasts
Do, dry or dry and be standby；
Step 2, the component per auxiliary carries out weighing 5 grams of the coptis, 15 grams of pollen, 15 grams of the dried rhizome of rehmannia, 5 grams of the tuber of dwarf lilyturf, the wind-weed by weight
5 grams, 10 grams of radix scrophulariae, 5 grams of the root of large-flowered skullcap, 8 grams of the root of straight ladybell, 5 grams of the root bark of Chinese wolf-berry, decoction is brewed into after mixing plus 15 grams of lotus root juice takes.
3. the preparation method of auxiliary treatment dog cat diabetes medicament as claimed in claim 2, it is characterised in that the auxiliary is controlled
Treat dog cat diabetes medicament using method be：By the coptis, pollen, the dried rhizome of rehmannia, the tuber of dwarf lilyturf, the wind-weed, radix scrophulariae, the root of large-flowered skullcap, the root of straight ladybell, the root bark of Chinese wolf-berry
Decoction is brewed into after mixing, plus lotus root juice takes, one time a day gavages.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710132278.8A CN106620233A (en) | 2017-03-07 | 2017-03-07 | Medicament for treating diabetes mellitus in dogs and cats in adjuvant way and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710132278.8A CN106620233A (en) | 2017-03-07 | 2017-03-07 | Medicament for treating diabetes mellitus in dogs and cats in adjuvant way and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106620233A true CN106620233A (en) | 2017-05-10 |
Family
ID=58847043
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710132278.8A Pending CN106620233A (en) | 2017-03-07 | 2017-03-07 | Medicament for treating diabetes mellitus in dogs and cats in adjuvant way and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106620233A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112826890A (en) * | 2021-03-25 | 2021-05-25 | 潘淑艳 | Medicine for treating diabetes |
-
2017
- 2017-03-07 CN CN201710132278.8A patent/CN106620233A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112826890A (en) * | 2021-03-25 | 2021-05-25 | 潘淑艳 | Medicine for treating diabetes |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103948786B (en) | Traditional Chinese medicine for treating diabetes | |
| CN104352863A (en) | Medicine for treating insulin dependent diabetes mellitus as well as preparation method thereof | |
| CN1899455B (en) | External use plaster for treating child heat diarrhea and preparing method | |
| CN101062256B (en) | Chinese traditional combination medicine for treating diabetes | |
| CN108853258A (en) | A kind of Chinese medicine composition that treating functional consitipation and its application | |
| CN105999057A (en) | Traditional Chinese medicine for treating diabetics | |
| CN106620233A (en) | Medicament for treating diabetes mellitus in dogs and cats in adjuvant way and preparation method thereof | |
| CN109771578A (en) | The composition for preventing and treating diabetes and complication | |
| CN104587175B (en) | A kind of Chinese medicine preparation for treating diabetes | |
| CN112451618A (en) | Traditional Chinese medicine composition for treating diabetic nephropathy | |
| CN103948844A (en) | Traditional Chinese herbal medicinal formula for treating diabetes mellitus and preparation method thereof | |
| CN108403904A (en) | Red stilbene Qinghua particle | |
| CN104107227B (en) | Chinese medicine rectum drop for the treatment of diabetic nephropathy and preparation method thereof | |
| CN103585495A (en) | Capsule for treating diabetic kidney damage | |
| CN108452160A (en) | A kind of ginseng stilbene Siberian cocklebur art preparation of breath in heptan training pancreas therapy treatment diabetes | |
| CN106728665A (en) | A kind of Chinese medicine preparation for treating diabetic nephropathy | |
| CN104587176B (en) | Treat the medicine of diabetes | |
| CN105770394A (en) | Diabetes treatment medicine | |
| CN104606474B (en) | Treat the Chinese medicine of diabetes | |
| CN105125903A (en) | Traditional Chinese medicinal composition for treating diabetes | |
| CN107802789A (en) | A kind of Chinese medicine preparation and its instructions of taking for preventing and treating diabetes | |
| Yu et al. | The Treatment of Diabetic Nephropathy with the Method of | |
| CN116942776A (en) | Pharmaceutical composition for treating urine retention, preparation and application thereof | |
| CN105412668A (en) | Traditional Chinese medicine composition for treating diabetes and preparation method of traditional Chinese medicine composition | |
| CN103520538A (en) | Medicinal composition for treating renal damage caused by diabetes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170510 |